-
Pharma Nobis Acquires Fagron’s Contract Manufacturing Business
contractpharma
February 07, 2022
Names Todd Daviau CEO.
-
GSK’s top scientist to quit, become CEO of anti-ageing start-up
Pharmaceutical-Technology
January 20, 2022
GSK’s chief scientific officer, Hal Barron, will head up the Silicon Valley biotech Altos Labs.
-
Nanoform convenes EGM to elect Jeanne Thoma as board member
prnasia
October 18, 2021
Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, will convene an extraordinary general meeting (EGM) on November 17, 2021, at 14:00 EEST to elect Jeanne Thoma as a new board member.
-
Kaleido Biosciences Announces New Chairperson Appointment to its Board of Directors
firstwordpharma
August 10, 2021
Kaleido Biosciences, Inc. (Nasdaq: KLDO) today announced the appointment of current Board member Theo Melas-Kyriazi as Chairperson of the Board of Directors effective August 9, 2021.
-
Stelis Biopharma Appoints Mark Womack as CEO
contractpharma
August 09, 2021
Assumes the role of chief executive with immediate effect and will be stationed at Stelis HQ in Bengaluru, India.
-
Hopeful of launching Covovax for adults in October this year, for children in Q1-2022: Serum CEO
firstwordpharma
August 09, 2021
Serum Institute of India CEO Adar Poonawalla said he is hopeful that Covovax will be launched in October, depending on DCGI approvals, for adults and for children by the first quarter of 2022, as reported The Economic Times.
-
ElectroPhysiology Frontiers announces appointment of Avi Fischer, M.D. as CEO
prnasia
August 03, 2021
ElectroPhysiology Frontiers S.p.A. (EPF), announced that its Board of Directors unanimously appointed Avi Fischer, M.D. as Chief Executive Officer (CEO) of the company and a member of its Board of Directors.
-
SCA Pharma Names Scott Luce as CEO
contractpharma
July 30, 2021
Luce’s priorities include serving new customer segments and fulfilling the company’s ambitious construction plan to expand capacity.
-
Thibault Jonckheere Named CEO of Exothera
contractpharma
June 02, 2021
The viral vector CDMO spinoff of Univercells is making an intranasal vaccine candidate for Covid-19 treatment.
-
Betagenon AB announces new CEO and new Chairman of the Board
prnasia
May 27, 2021
Betagenon AB today announced that James Hall BM, BCh, D.Phil has joined this month as CEO. Dr. Hall brings extensive senior healthcare and life science experience, including 12 years with AstraZeneca.